UnitedHealth Group (NYSE:UNH) Shares Gap Up After Earnings Beat

Key Points

• UnitedHealth beat earnings expectations: Adjusted third-quarter EPS was $4.69, above the roughly $4.12–$4.14 analyst consensus and up substantially from $2.92 a year earlier.
• Full-year guidance was raised: The company now expects 2026 earnings of approximately $19.50–$20.00 per share, supported by improved medical-cost management and investments in value-based care and artificial intelligence.
• Growth remains mixed: Optum Health revenue declined, potentially limiting overall growth, while UnitedHealth maintained a $2.32 quarterly dividend, equivalent to a 2.5% yield.

UnitedHealth Group Incorporated (NYSE:UNH - Get Free Report) gapped up before the market opened on Tuesday after the company announced better than expected quarterly earnings. The stock had previously closed at $378.52, but opened at $397.63. UnitedHealth Group shares last traded at $374.7850, with a volume of 3,137,251 shares changing hands.

The healthcare conglomerate reported $4.69 EPS for the quarter, topping analysts' consensus estimates of $4.14 by $0.55. UnitedHealth Group had a net margin of 3.14% and a return on equity of 16.53%. UnitedHealth Group's revenue was down .4% compared to the same quarter last year. During the same quarter in the prior year, the business posted $2.59 EPS.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, September 22nd. Shareholders of record on Monday, September 14th were given a $2.32 dividend. This represents a $9.28 dividend on an annualized basis and a yield of 2.5%. The ex-dividend date was Monday, September 14th. UnitedHealth Group's dividend payout ratio is 59.72%.

Key Headlines Impacting UnitedHealth Group

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: UnitedHealth reported adjusted third-quarter earnings of $4.69 per share, ahead of the $4.12 analyst consensus and up from $2.92 a year earlier. Reported net income was $4.11 billion, or $4.56 per share, compared with $2.35 billion, or $2.59 per share, in the prior-year quarter. UnitedHealth Group Q3 Earnings and Revenues Top Estimates
• Positive Sentiment: The company raised its full-year 2026 earnings outlook to approximately $19.50-$20.00 per share, signaling greater confidence in profitability and supporting the stock’s rally. UnitedHealth Group tops estimates and hikes profit outlook
• Positive Sentiment: Medical-cost management showed improvement, a key issue for health insurers. UnitedHealth also cited progress from value-based care and artificial-intelligence investments, suggesting potential support for longer-term margins and efficiency. UnitedHealth Earnings Beat Wall Street Estimates
• Neutral Sentiment: Optum Health revenue declined, creating a potential constraint on overall growth even as the company delivered better earnings and raised guidance. Investors are likely to watch whether improved margins can offset weaker top-line performance. UnitedHealth raises guidance as Optum Health revenue slips

Analyst Ratings Changes

Several brokerages have recently issued reports on UNH. Sanford C. Bernstein reiterated an "outperform" rating and set a $512.00 price target (up from $492.00) on shares of UnitedHealth Group in a research report on Wednesday, September 2nd. Erste Group Bank lowered UnitedHealth Group from a "buy" rating to a "hold" rating in a report on Thursday, August 27th. Weiss Ratings raised UnitedHealth Group from a "hold (c-)" rating to a "hold (c)" rating in a report on Thursday. Cantor Fitzgerald boosted their price target on shares of UnitedHealth Group from $440.00 to $495.00 and gave the stock an "overweight" rating in a research report on Friday, July 17th. Finally, Deutsche Bank Aktiengesellschaft upped their price target on shares of UnitedHealth Group from $370.00 to $467.00 and gave the company a "hold" rating in a report on Friday, July 17th. Twenty analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the company. According to data from MarketBeat, UnitedHealth Group presently has a consensus rating of "Moderate Buy" and a consensus target price of $462.59.

Insider Transactions at UnitedHealth Group

In other UnitedHealth Group news, CEO Patrick Conway sold 1,169 shares of UnitedHealth Group stock in a transaction that occurred on Friday, August 21st. The shares were sold at an average price of $390.00, for a total value of $455,910.00. Following the transaction, the chief executive officer owned 15,328 shares in the company, valued at approximately $5,977,920. The trade was a 7.09% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Company insiders own 0.19% of the company's stock.

Hedge Funds Weigh In On UnitedHealth Group

Hedge funds have recently modified their holdings of the stock. NorthCrest Asset Manangement LLC raised its position in shares of UnitedHealth Group by 41.3% during the third quarter. NorthCrest Asset Manangement LLC now owns 24,897 shares of the healthcare conglomerate's stock worth $9,235,000 after purchasing an additional 7,273 shares during the period. Tilia Fiduciary Partners Inc. boosted its position in shares of UnitedHealth Group by 3.1% in the 3rd quarter. Tilia Fiduciary Partners Inc. now owns 7,237 shares of the healthcare conglomerate's stock valued at $2,657,000 after purchasing an additional 217 shares during the period. Argus Investors Counsel Inc. acquired a new position in shares of UnitedHealth Group in the 3rd quarter valued at $419,000. Castleview Partners LLC increased its stake in UnitedHealth Group by 3.4% in the 3rd quarter. Castleview Partners LLC now owns 9,191 shares of the healthcare conglomerate's stock worth $3,374,000 after purchasing an additional 303 shares in the last quarter. Finally, Stokes Capital Advisors LLC raised its holdings in UnitedHealth Group by 5.3% during the 3rd quarter. Stokes Capital Advisors LLC now owns 2,882 shares of the healthcare conglomerate's stock worth $1,058,000 after buying an additional 144 shares during the period. 87.86% of the stock is currently owned by institutional investors and hedge funds.

UnitedHealth Group Trading Down 0.7%

The company has a current ratio of 0.78, a quick ratio of 0.78 and a debt-to-equity ratio of 0.66. The stock has a market cap of $337.36 billion, a price-to-earnings ratio of 24.19, a P/E/G ratio of 1.43 and a beta of 0.60. The company has a fifty day simple moving average of $388.03 and a 200-day simple moving average of $381.81.

About UnitedHealth Group

UnitedHealth Group Incorporated NYSE: UNH is a diversified health care and well-being company serving individuals, employers, health care providers and government programs. Its operations are organized primarily through UnitedHealthcare and Optum.

UnitedHealthcare provides health benefit plans and services, including employer-sponsored coverage, individual and family plans, Medicare and Medicaid offerings, and other government-supported programs. Its services include health insurance administration, pharmacy benefits and care management.

Optum provides health care services, technology and data solutions, pharmacy services, and analytics to health plans, employers, government agencies, health care providers and consumers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.